Cover Image
市場調查報告書

ImmunoCellular Therapeutics, Ltd.的產品平台分析

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226216
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
ImmunoCellular Therapeutics, Ltd.的產品平台分析 ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015
出版日期: 2015年05月29日 內容資訊: 英文 37 Pages
簡介

ImmunoCellular Therapeutics, Ltd.ha是開發各種癌症的免疫治療藥的臨床階段生物科技企業。

本報告提供ImmunoCellular Therapeutics, Ltd.上的治療藥開發平台現狀及各開發階段比較分析,提供藥物標的,作用機制,給藥途徑,各類型分子的治療藥評估,以及最新的企業新聞和發表,後期階段及中止計劃的相關資訊等。

ImmunoCellular Therapeutics, Ltd.的基本資料

ImmunoCellular Therapeutics, Ltd.概要

  • 主要資訊
  • 企業資料

ImmunoCellular Therapeutics, Ltd.:R&D概要

  • 主要的治療範圍

ImmunoCellular Therapeutics, Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

ImmunoCellular Therapeutics, Ltd.:開發中產品概況

  • 位於臨床實驗階段的開發中產品
    • 位於第二階段的產品/聯合治療模式
    • 位於第一階段的產品/聯合治療模式
  • 位於初期階段的開發中產品
  • IND/CTA Filed Products/Combination Treatment Modalities
    • 位於前臨床階段的產品/聯合治療模式

ImmunoCellular Therapeutics, Ltd.:藥物簡介

  • ICT-107
  • ICT-121
  • ICT-140
  • ICT-037
  • ICT-109
  • ICT-69

ImmunoCellular Therapeutics, Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各類型分子
  • 各作用機制

ImmunoCellular Therapeutics, Ltd.:最近的開發平台趨勢

ImmunoCellular Therapeutics, Ltd.:暫停中的計劃

ImmunoCellular Therapeutics, Ltd.:企業發表

ImmunoCellular Therapeutics, Ltd.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07106CDB

Summary

Global Markets Direct's, 'ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015', provides an overview of the ImmunoCellular Therapeutics, Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ImmunoCellular Therapeutics, Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of ImmunoCellular Therapeutics, Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of ImmunoCellular Therapeutics, Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the ImmunoCellular Therapeutics, Ltd.'s pipeline products

Reasons to buy

  • Evaluate ImmunoCellular Therapeutics, Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of ImmunoCellular Therapeutics, Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the ImmunoCellular Therapeutics, Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of ImmunoCellular Therapeutics, Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of ImmunoCellular Therapeutics, Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of ImmunoCellular Therapeutics, Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • ImmunoCellular Therapeutics, Ltd. Snapshot
    • ImmunoCellular Therapeutics, Ltd. Overview
    • Key Information
    • Key Facts
  • ImmunoCellular Therapeutics, Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • ImmunoCellular Therapeutics, Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • ImmunoCellular Therapeutics, Ltd. - Pipeline Products Glance
    • ImmunoCellular Therapeutics, Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • ImmunoCellular Therapeutics, Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • ImmunoCellular Therapeutics, Ltd. - Drug Profiles
    • ICT-107
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ICT-121
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ICT-037
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ICT-109
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapies for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • ImmunoCellular Therapeutics, Ltd. - Pipeline Analysis
    • ImmunoCellular Therapeutics, Ltd. - Pipeline Products by Target
    • ImmunoCellular Therapeutics, Ltd. - Pipeline Products by Route of Administration
    • ImmunoCellular Therapeutics, Ltd. - Pipeline Products by Molecule Type
    • ImmunoCellular Therapeutics, Ltd. - Pipeline Products by Mechanism of Action
  • ImmunoCellular Therapeutics, Ltd. - Recent Pipeline Updates
  • ImmunoCellular Therapeutics, Ltd. - Dormant Projects
  • ImmunoCellular Therapeutics, Ltd. - Company Statement
  • ImmunoCellular Therapeutics, Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • ImmunoCellular Therapeutics, Ltd., Key Information
  • ImmunoCellular Therapeutics, Ltd., Key Facts
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Indication, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Stage of Development, 2015
  • ImmunoCellular Therapeutics, Ltd. - Monotherapy Products in Pipeline, 2015
  • ImmunoCellular Therapeutics, Ltd. - Phase II, 2015
  • ImmunoCellular Therapeutics, Ltd. - Phase I, 2015
  • ImmunoCellular Therapeutics, Ltd. - Preclinical, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Target, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Route of Administration, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Molecule Type, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline Products by Mechanism of Action, 2015
  • ImmunoCellular Therapeutics, Ltd. - Recent Pipeline Updates, 2015
  • ImmunoCellular Therapeutics, Ltd. - Dormant Developmental Projects,2015
  • ImmunoCellular Therapeutics, Ltd., Subsidiaries

List of Figures

  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Top 10 Indication, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Stage of Development, 2015
  • ImmunoCellular Therapeutics, Ltd. - Monotherapy Products in Pipeline, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Top 10 Target, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • ImmunoCellular Therapeutics, Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top